GLUE
Monte Rosa Therapeutics Inc
12.60$
-0.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.02 | 1.89 | |
| 0.00 | 0.01 | 0.05 | 0.18 | 0.12 | 0.11 | 0.13 | |
| 0.00 | -0.01 | -0.05 | -0.18 | -0.12 | 0.91 | 1.76 | |
| 0.17 | 0.53 | 1.23 | 1.80 | 2.04 | 1.64 | 2.16 | |
| 0.01 | 0.09 | 0.34 | 0.58 | 0.62 | 0.48 | 0.56 | |
| 0.18 | 0.62 | 1.57 | 2.38 | 2.67 | 2.01 | 2.59 | |
| -0.18 | -0.64 | -1.57 | -2.38 | -2.79 | -1.10 | -0.83 | |
| 0.00 | 0.00 | 0.02 | 0.08 | – | – | – | |
| -0.18 | -0.82 | -1.59 | -2.30 | -2.63 | -0.95 | -0.61 | |
| 0.01 | 0.00 | -0.04 | -0.08 | 0.01 | 0.03 | -0.02 | |
| -0.18 | -0.82 | -1.59 | -2.30 | -2.63 | -0.98 | -0.59 | |
| -0.17 | -0.62 | -1.54 | -2.14 | -2.51 | -0.84 | -0.48 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.